![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HCV Screening/treatment in UK Prisons Can be Cost-Effective - IS INCREASED HCV CASE-FINDING COMBINED WITH 8 OR 12 WEEK INTERFERON-FREE DIRECT-ACTING ANTIVIRAL TREATMENT COST EFFECTIVE IN UK PRISONS?
A COST UTILITY ANALYSIS INCLUDING TREATMENT AS PREVENTION BENEFITS
|
|
|
HCV Screening/treatment in UK Prisons Can be Cost-Effective, New Modeling Study by Natasha Martin: "Scaling-up treatment to PWID could substantially increase-cost-effectiveness due to prevention benefit"
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
Natasha Martin, Associate Professor, UC San Diego
Prof Matthew Hickman & Prof Peter Vickerman, Univ of Bristol
![EASL1.gif](../images/042715/042715-6/EASL1.gif)
![EASL2.gif](../images/042715/042715-6/EASL2.gif)
![EASL3.gif](../images/042715/042715-6/EASL3.gif)
![EASL4.gif](../images/042715/042715-6/EASL4.gif)
![EASL5.gif](../images/042715/042715-6/EASL5.gif)
![EASL6.gif](../images/042715/042715-6/EASL6.gif)
![EASL7.gif](../images/042715/042715-6/EASL7.gif)
![EASL8.gif](../images/042715/042715-6/EASL8.gif)
![EASL9.gif](../images/042715/042715-6/EASL9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|